Neutrophil glucose flux as a therapeutic target in antiphospholipid syndrome.
Tambralli A, Harbaugh A, NaveenKumar SK, Radyk MD, Rysenga CE, Sabb K, Hurley JM, Sule GJ, Yalavarthi S, Estes SK, Hoy CK, Smith T, Sarosh C, Madison JA, Schaefer JK, Sood SL, Zuo Y, Sawalha AH, Lyssiotis CA, Knight JS.
Tambralli A, et al. Among authors: knight js.
J Clin Invest. 2024 Jun 13;134(15):e169893. doi: 10.1172/JCI169893.
J Clin Invest. 2024.
PMID: 38869951
Free PMC article.